-
Chardan: R1 RCM Will Make A Full Recovery
Tuesday, September 4, 2018 - 2:41pm | 333Read More...Even as it reflects on 56-percent year-over-year gains, R1 RCM Inc (NASDAQ: RCM) has struck an “attractive inflection point,” according to Chardan Capital Markets. The Rating Analyst Steven Wardell initiated coverage on R1 RCM with a Buy rating and a $17 price target. The Thesis Chardan...
-
Despite Guidance Miss, Teladoc Still Attractive
Monday, January 9, 2017 - 1:16pm | 286Read More...Chardan Capital Markets is bullish on Teladoc Inc (NYSE: TDOC) despite the software firm guiding preliminary 2017 revenue below the Street. Teladoc, which provides telehealth services to health plans and employers, expects 2017 revenue of $182.5 million at the midpoint, which represents a 49...
-
WageWorks Shares Could Rise 16% Over Next Year
Wednesday, November 30, 2016 - 10:04am | 257Read More...Channel checks indicate strong growth for Wageworks Inc (NYSE: WAGE) over the next couple of years from multiple sources, Chardan Capital Markets’ Steven Wardell said in a report. He initiated coverage on the company with a Buy rating and a price target of $86. WageWorks’ growth over...
-
Fitbit Investors Take Profits Following Favorable Reaction To Blaze, Alta Shipment News
Friday, April 1, 2016 - 11:31am | 498Read More...The Fitbit Inc (NYSE: FIT) battle of bull versus bear continued on Friday as analysts at BlueFin Research Partners issued cautious commentary, while analysts at Leerink countered with a positive sentiment. Shares of Fitbit were higher by more than 1 percent on Friday, adding to the more than 25...
-
Fitbit's Chinese Threat Is Overblown, Research Says
Wednesday, November 18, 2015 - 11:59am | 332Read More...The share price of Fitbit Inc (NYSE: FIT) has declined 35.32 percent year-to-date, reaching a low of $27.86 on November 13. Leerink’s Steven Wardell has reiterated an Outperform rating on the company, with a price target of $81. Wardell expects the company to maintain its market...
-
Get Excited About WebMD's 'Killer' Product
Friday, November 13, 2015 - 11:13am | 336Read More...WebMD Health Corp. (NASDAQ: WBMD) shares have been volatile in 2015, and are up 9 percent year-to-date. Leerink Partners’ Steven Wardell maintained an Outperform rating on the company, while raising the price target from $54 to $55. Medscape is emerging as a killer app on mobile...
-
How Fitbit Doubles From Here
Tuesday, November 3, 2015 - 11:52am | 268Read More...Fitbit Inc (NYSE: FIT) shares have appreciated 29.72 percent over the past six months, from a low of $29.68 on June 18. Leerink’s Steven Wardell has reiterated an Outperform rating on the company, while raising the price target from $79 to $81. The company posted higher-than-...
-
Leerink Now More Confident In Fitbit Outlook After Speaking With This CEO
Tuesday, October 27, 2015 - 11:16am | 351Read More...Fitbit Inc (NYSE: FIT) shares declined 14.45 percent over the past three months, from a high of $51.64 on August 5. Leerink’s Steven Wardell has maintained an Outperform rating on the company. Wardell expressed increased confidence in the expectations for Fitbit, following a meeting...
-
'Telehealth' Is Coming To The Mainstream In A Pure-Play Package
Thursday, August 27, 2015 - 9:35am | 281Read More...Teladoc Inc (NYSE: TDOC) shares are down 22 percent over the past month, declining steadily since August 10. Leerink Partners’ Steven Wardell initiated coverage of the company with an Outperform rating and a price target of $35. Telehealth has made an entry into the mainstream,...
-
Leerink Analyst Sees Long-Term Potential For Fitbit
Thursday, June 25, 2015 - 3:52pm | 435Read More...In a report published Wednesday, Leerink analyst Steven Wardell initiated coverage of Fitbit Inc (NYSE: FIT) with an Outperform rating and a $44 price target. The stock is currently trading at about $37 per share. He says that "powerful secular trends have created important new markets for...
-
Leerink Initiates Coverage Of Healthequity, Sees Upside Potential Amid Rising Healthcare Costs
Friday, March 6, 2015 - 2:30pm | 244Read More...In a report issued Friday, Leerink Partners LLC initiated coverage on Healthequity Inc (NASDAQ: HQY) at Outperform with a $28.00 price target. Analyst Steven Wardell wrote in a note to clients, "We anticipate that the 2015 benefits season, which Healthequity will report on in its F4Q14...
